PATENT CLAIM ANALYSIS

Application Number: 15910617
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["424", "186100"]

Abstract:
Coronaviruses, vaccines comprising the same, and methods for preventing disease. One embodiment of such includes a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a non-structural protein (nsp)-15, the replicase gene encoding the nsp15 and causes any change, including mutations and/or deletions, that affects the stability or activity of the nsp15.

Claim (Index 5):
The coronavirus of  claim 4 , wherein the Coronavirinae virus is chosen from the group consisting of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), human coronaviruses 229E (HCoV-229E), 0C43 (HCoV-0C43), HKU1 (HCoV-HKU1), and NL63 (HCoV-NL63), feline infectious peritonitis virus (FIPV), canine coronavirus (CCoV), infectious bronchitis virus (IBV) of chickens, bovine coronavirus (BoCoV), and porcine coronaviruses including transmissible gastroenteritis virus (TGEV), porcine delta coronavirus (PDCoV), porcine epidemic diarrhea virus (PEDV), porcine respiratory coronavirus (PRCV), and porcine hemagglutinating encephalomyelitis coronavirus (PHE-CoV).

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 1.44444
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15328179', '14707356', '11135603', '10714534', '14413385']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7866552124145957
- 35 USC 102 Novelty (BERT): 0.5217378903713974
- Combined Prediction Score: 0.7601634802102759
- Mean Citation Score: 308.185418
- Max Citation Score: 333.40042
- Similarity Product: 240.3179182606017

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test